Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy

Fishbein, Anna; Lor, Jennifer; Penedo, Frank J.; Forrest, Christopher B.; Griffith, James W.; Paller, Amy S.

doi:10.1016/j.jaad.2020.05.138

Cited by 10 publications

(5 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This longitudinal study not only builds upon earlier cross-sectional investigations with comparable sample sizes that examined the validity of PROMIS measures with actigraphy sleep related data, but also uniquely examines how changes in the immediate postoperative period are associated with longitudinal postoperative outcomes (Fishbein et al, 2020;Hanish et al, 2017;McMahon et al, 2020).…”

Section: Discussionmentioning

confidence: 96%

“…For example, consensus groups recommend the use of computer adaptive testing enabled Patient Reported Outcome Measurement Information System (PROMIS ® ) to increase the speed and accuracy of postoperative assessments (Broderick et al, 2013;Cook et al, 2014). Previous studies integrating actigraphy and PROMIS measures together have predominately been conducted in paediatric and adolescent patient populations or over a shorter postoperative study period (Fishbein et al, 2020;Hanish et al, 2017;McMahon et al, 2020). Among adults undergoing minor elective surgeries, actigraphy data have been found to be capable of detecting relatively minor differences in sleep and activity, even when PROMIS domain scores related to sleep disturbance lacked statistically significant differences (McMahon et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Changes in actigraphy metrics associated with PROMIS measures after orthopaedic surgery

Giordano

Kane

Rodríguez

et al. 2022

Int J of Nursing Practice

View full text Add to dashboard Cite

Aim: This study examined the feasibility of integrating actigraphy devices into orthopaedic surgical settings to assess the concurrent validity between objective actigraphy data and PROMIS measures. Additionally, the association between changes in actigraphy data and longitudinal changes in PROMIS measures was examined.Methods: Data were collected from 17 participants using actigraphy devices the week prior to and after orthopaedic surgery from 02/2019 to 03/2020. Participants completed PROMIS measures (Physical Function, Sleep Disturbance, Pain Interference) preoperatively and up to 6 months postoperatively. Nonparametric correlations (r s ) assessed for concurrent validity. Linear mixed-effects models examined the association between changes in actigraphy data and PROMIS measures.Results: Prolonged wake after sleep onset was associated with increased sleep disturbances (r s = 0.49; p = 0.045) and pain interference (r s = 0.51; p = 0.04). Changes in pain interference were correlated with increased awakenings (r s = 0.54; p = 0.03).Increased wake after sleep onset was associated with worsening sleep disturbance (β = 0.12; p = 0.01) and pain interference scores over the postoperative period (β = 0.12; p = 0.02).Conclusions: This study is among the first to examine changes in objective actigraphy data and longitudinal PROMIS measures following orthopaedic surgery and illustrates the feasibility of incorporating actigraphy into surgical settings to evaluate postoperative recovery.

show abstract

Section: Discussionmentioning

confidence: 96%

Section: Introductionmentioning

confidence: 99%

Changes in actigraphy metrics associated with PROMIS measures after orthopaedic surgery

Giordano

Kane

Rodríguez

et al. 2022

Int J of Nursing Practice

View full text Add to dashboard Cite

show abstract

“…There is a clear need for validated tools that can accurately reflect the impact of AD on sleep in this patient population. Beyond the use of the CDLQI and POEM in future clinical trials with pediatric AD patient populations, newer tools under development, such as the Patient-Reported Outcomes Measurement Information System, may be able to provide higher-quality sleep data in these patients [ 31 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis

Fowler

Sugarman

Sher

et al. 2023

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Introduction: Using data from three clinical trials, the effect of crisaborole treatment on sleep outcomes for pediatric patients with atopic dermatitis (AD) and their families was examined. Methods: This analysis comprised patients aged 2 to \ 16 years from the double-blind phase 3 CrisADe CORE 1 (NCT02118766) and CORE 2 (NCT02118792) studies, families of patients aged 2 to \ 18 years from CORE 1 and CORE 2, and patients aged 3 months to \ 2 years from the open-label phase 4 CrisADe CARE 1 study (NCT03356977), all with mild-to-moderate AD who received crisaborole ointment 2% twice daily for 28 days. Sleep outcomes were assessed via the Children's Dermatology Life Quality Index and Dermatitis Family Impact questionnaires in CORE 1 and CORE 2 and the Patient-Oriented Eczema Measure questionnaire in CARE 1. Results: In CORE 1 and CORE 2, a significantly lower proportion of crisaborole-treated patients than vehicle-treated patients reported sleep disruption at day 29 (48.5% versus 57.7%, p = 0.001). The proportion of families whose sleep was affected by their child's AD in the preceding week was also significantly lower in the crisaborole group (35.8% versus 43.1%, p = 0.02) at day 29. At day 29 in CARE 1, the proportion of crisaborole-treated patients who experienced C 1 night of disturbed sleep in the previous week decreased by 32.1% from baseline. Conclusion: These results suggest that crisaborole improves sleep outcomes in pediatric patients with mild-to-moderate AD and their families.

show abstract

“…Subjects were included if they were between 1 and 4 years of age and had AD (parent reported “yes” to the question, “Has a doctor or another health care provider told you that your child has eczema?”). Our primary measure of AD severity was the POEM and has been used in our previous studies 24,25 . Adjusted POEM scores (without itch and sleep question) were calculated into a composite score for statistical analysis in a linear regression model to isolate the contribution of itch and sleep health as predictor variables in the model (Additional methods in the ).…”

Section: Methodsmentioning

confidence: 99%

Parent report of sleep health and attention regulation in a cross‐sectional study of infants and preschool‐aged children with atopic dermatitis

Zhou

Nili

Blackwell

et al. 2021

Pediatric Dermatology

Self Cite

View full text Add to dashboard Cite

Background/Objectives Older children with atopic dermatitis (AD) suffer from poor sleep and attention problems. However, until recently, the dearth of developmentally sensitive assessment tools impeded characterization in younger children. We aimed to characterize sleep and attention problems in young children with AD and identify modifiable factors. Methods A cross‐sectional study of children with AD aged 1–4 years was stratified by disease severity (Patient‐Oriented Eczema Measure), age, and racial/ethnic groups. Developmentally sensitive surveys assessed attention (Multidimensional Assessment Profile of Attention Regulation), sleep, and itch (Patient‐Reported Outcomes Measurement Information System). Linear regression models identified predictors of sleep health and attention dysregulation. Results Parents (n = 60) of children aged 2.78 ± 0.98 years with severe (n = 25), moderate (n = 25), or mild (n = 10) AD were recruited across the United States. Significantly reduced sleep health (T‐score ≥ 60) was reported in 86% of children with moderate/severe disease (n = 43), and 50% had ≥5 nights of disturbed sleep per week. A suboptimal sleep environment was identified with 32% of children with too much light, noise, or electronic device usage. With regard to attention regulation, in children with severe AD, 80% had trouble sitting still and 72% of children had trouble paying attention no matter their surroundings. In fully adjusted models, AD severity was a significant predictor of poor sleep health (B = 0.79 [0.31–1.28], p < .01) and attention dysregulation (B = 1.22 [0.51–1.93], p < .01). Conclusions More severe AD correlates with poor sleep health and attention dysregulation. In addition to aggressive treatment of AD, clinicians should advise on modifiable sleep hygiene practices and consider screening for attention dysregulation in young children.

show abstract

Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy

Cited by 10 publications

References 24 publications

Changes in actigraphy metrics associated with PROMIS measures after orthopaedic surgery

Changes in actigraphy metrics associated with PROMIS measures after orthopaedic surgery

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis

Parent report of sleep health and attention regulation in a cross‐sectional study of infants and preschool‐aged children with atopic dermatitis

Contact Info

Product

Resources

About